[Sublingual vs subcutaneous immunotherapy].
At the end of the 1980 decade, the first reports about the use of oral and sublingual routes of immunotherapy were published. This article reviews some reports comparing sublingual vs subcutaneous immunotherapy.
Olivé Pérez
Alfonso
A
Institut Català de la Salud, Cap Besos, Barcelona, España.
D000286:Administration, Sublingual; D000328:Adult; D000485:Allergens / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D000818:Animals; D002648:Child; D002986:Clinical Trials as Topic; D003888:Desensitization, Immunologic / Q000009:adverse effects / Q000379:methods*; D004311:Double-Blind Method; D006801:Humans; D007263:Infusions, Parenteral; D007279:Injections, Subcutaneous; D008925:Mites; D006109:Poaceae; D011058:Pollen; D012130:Respiratory Hypersensitivity / Q000628:therapy*; D012449:Safety; D016896:Treatment Outcome
D000485:Allergens